Your browser doesn't support javascript.
loading
One-pot synthesis of polyhydroquinoline-1,2,3-triazole hybrids in deep eutectic solvent as anti-leishmanial agents and molecular modeling studies.
Molaei, Soheila; Farhadi, Ghazaleh; Talezari, Mina; Gholizadeh, Negin; Mahnam, Karim; Keivanloo, Ali; Sepehri, Saghi.
Afiliação
  • Molaei S; Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Farhadi G; Students Research Committee, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Talezari M; Faculty of Chemistry, Shahrood University of Technology, Shahrood, Iran.
  • Gholizadeh N; Students Research Committee, Public Health School, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Mahnam K; Department of Biology, Faculty of Sciences, Shahrekord University, Shahrekord, Iran.
  • Keivanloo A; Faculty of Chemistry, Shahrood University of Technology, Shahrood, Iran.
  • Sepehri S; Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
J Biomol Struct Dyn ; : 1-17, 2023 Jun 16.
Article em En | MEDLINE | ID: mdl-37325813
The novel hybrids with 1,2,3-triazole and polyhydroquinoline scaffolds were successfully synthesized by multicomponent reaction of propargyloxybenzaldehyde, 1,3-cyclohexadione, ethylacetoacetate and ammonium acetate followed through click reaction in the presence of deep eutectic solvent ChCl/ZnCl2 as an efficient catalyst. Their anti-leishmanial activity was evaluated against amastigote and promastigote forms of L. tropica, L. major, and two different species of L. infantum. Furthermore, to determine the cytotoxicity of the hybrids, they were evaluated against the murine macrophage cell line J774.A1. Based on the results, three hybrids showed the highest antileishmanial activity. However, they revealed low cytotoxicity. Hybrid 6j was the most potent compound against both the forms of all leishmanial types, with IC50 = 13.5 and 11.9 µg/mL for L. major, 37.5 and 25 µg/mL for L. tropica, 17.5 and 20 µg/mL for L. infantum (MCAN/IR//96/LON49) and 35.5 and 30 µg/mL for L. infantum (MCAN/ES/98/LIM-877), respectively. Finally, molecular docking and molecular dynamics simulations were also performed to identify possible mechanism antileishmanial activity.Communicated by Ramaswamy H. Sarma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article